RACHEL DE LIMA: Open Payments
NPI 1215596788 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,584 in 74 payments from 9 companies in 2025. Trend: 2023 $375 · 2024 $1,313 · 2025 $5,584
Speaker / faculty: $4,400Food & beverage: $1,053Travel & lodging: $131
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $4,781 |
| Otsuka America Pharmaceutical, Inc. | 10 | $200 |
| E.R. Squibb & Sons, L.L.C. | 4 | $176 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $158 |
| Axsome Therapeutics, Inc. | 6 | $157 |
| Alkermes, Inc. | 1 | $57 |
| Indivior Inc. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Braeburn Inc. | 1 | $14 |
Products named: VRAYLAR, COBENFY, CAPLYTA, Auvelity, ABILIFY MAINTENA, ARISTADA, ABILIFY ASIMTUFII, SUBLOCADE.
Industry payments across OH — which companies pay providers there.
